NGENF Nervgen Consolidation continues Possible entry ahead Viés de alta

NervGen Pharma Corp.OTC

Descrição

⋅ 18 de Ago de 2021 02:05

Nice long ~2 year consolidation is in progress, recent reject from the top side of wedge will present entry opportunities

Entry target ~ 1.15-1.35 (1.25 average)

Interesting medical treatments currently in trials

Long term play

Mais